State Street’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,162
| Closed | -$22.8K | – | 4620 |
|
|
2023
Q2 | $22.8K | Sell |
3,162
-140
| -4% | -$1.01K | ﹤0.01% | 4579 |
|
|
2023
Q1 | $24.3K | Hold |
3,302
| – | – | ﹤0.01% | 4652 |
|
|
2022
Q4 | $22K | Hold |
3,302
| – | – | ﹤0.01% | 4717 |
|
|
2022
Q3 | $34K | Sell |
3,302
-64
| -2% | -$659 | ﹤0.01% | 4741 |
|
|
2022
Q2 | $41K | Sell |
3,366
-13,408
| -80% | -$163K | ﹤0.01% | 4761 |
|
|
2022
Q1 | $355K | Sell |
16,774
-980
| -6% | -$20.7K | ﹤0.01% | 4180 |
|
|
2021
Q4 | $1.07M | Buy |
17,754
+1,848
| +12% | +$111K | ﹤0.01% | 3801 |
|
|
2021
Q3 | $1.49M | Buy |
15,906
+2,178
| +16% | +$204K | ﹤0.01% | 3694 |
|
|
2021
Q2 | $2.27M | Buy |
13,728
+3,924
| +40% | +$649K | ﹤0.01% | 3524 |
|
|
2021
Q1 | $1.89M | Buy |
+9,804
| New | +$1.89M | ﹤0.01% | 3462 |
|